Thursday, May 06, 2021 5:00:26 PM
MAY
- Clone-3 test results from Univ Montana
- ITV-1 Clinical Trials timeline provided
- Audited 10-K for 2019
- Audited 10-K for 2020
- 10-Q for Q1, 2021
- OTCQB application submission (?)
JUNE
- Strousbourg France test results of CL3 recombinant
- Identidied conserved sites of HTLV-1/2 using AI
- Finish production of COVID antibodies
- First delivery of $50MM valued contract to PWA
JULY
- Cl3 Recombinant Animal Trials begins
- Fast-Track clinical studies of COVID antibodies begins
- Production of HTLV-1/2 antibodies begins
As Chandra said, there are "milestone-linked partnerships". Here are the milestones. Know what you hold ?
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM